Nov 07 2022
Liver cirrhosis is a disease widely seen all over the world. Approximately one million people die annually due to liver cirrhosis. It is a pathological condition in which liver fibrosis progresses and liver function declines due to factors such as viral hepatitis, alcoholic liver disease, and non-alcoholic steatohepatitis. The development of effective treatments is urgent.
The research group Professor KAMIMURA Kenya (Department of General Medicine, Niigata University School of Medicine in the Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences Niigata University), Assistant Professor SAKAI Norihiro and Professor TERAI Shuji in the Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Professor OHYAMA Kaname in the Department of Hospital Pharmacy of Nagasaki University Hospital, Assistant Professor MIYAMOTO Hirotaka in the Department of Pharmaceutics, Nagasaki University Institute of Biomedical Sciences, and Professor NAKASHIMA Mikiro in the Department of Pharmacy Practice, Nagasaki University Institute of Biomedical Sciences used a drug repositioning1 method based on the alteration of gene expression2 and revealed in mice that letrozole3, which is used to treat breast cancer, is effective in suppressing the progression of liver fibrosis.
Gene expression is the process of synthesizing proteins based on genetic information and converting them into structures and functions in cells. This change is called the alteration of gene expression.
2.Alteration of gene expression
A method of discovering new efficacy of an approved drug whose safety and pharmacokinetics have been confirmed and developing it as a therapeutic drug for a different disease.
A type of aromatase inhibitor, a drug used to treat breast cancer.
4.Chimeric mice with humanized hepatocytes
Special mice whose livers are mostly composed of human hepatocytes. More than 80 percent of the mice used in our study have human hepatocytes.
Journal: Journal of Gastroenterology
Title: Letrozole ameliorates liver fibrosis through the inhibition of the CTGF pathway and 17β-hydroxysteroid dehydrogenase 13 expression
Authors: Norihiro Sakai, Kenya Kamimura, Hirotaka Miyamoto, Masayoshi Ko, Takuro Nagoya, Toru Setsu, Akira Sakamaki, Takeshi Yokoo, Hiroteru Kamimura, Hiroyuki Soki, Ayako Tokunaga, Tatsuo Inamine, Mikiro Nakashima, Hatsune Enomoto, Kazuki Kousaka, Hidehisa Tachiki, Kaname Ohyama, and Shuji Terai
The article was released in EurekAlert, the online publication of the American Association for the Advancement of Science.
Human early-onset dementia caused by DAP12 deficiency reveals a unique signature of dysregulated microglia
A novel NONO variant that causes developmental delay and cardiac phenotypes
Direct evaluation of neuroaxonal degeneration with the causative genes of neurodegenerative diseases in drosophila using the automated axon quantification system, MeDUsA